MAPT and early-onset autosomal dominant Alzheimer disease: There are several CSF biomarkers for brain disorders, for example, tau, phosphorylated tau, and Aβ42 can be used for the diagnosis of Alzheimer’s disease with a high (~90%) sensitivity and accuracy [12].